ALB and Sepsis: A systematic review with sequential analysis of all-cause mortality from major trials like SAFE, ALBIOS, and EARSS concluded that human albumin solutions did not reduce all-cause mortality in sepsis of any severity, even in patients with hypoalbuminemia [12, 13, 33, 34].